Pfizer
US CDC will not publish report showing COVID vaccine effectiveness
"Scientific reports are routinely reviewed at multiple levels to ensure they meet the highest standards before publication," said HHS spokesperson Andrew Nixon.
'When I grow up, I want to be like you': remembering Morris Kahn's most productive years - opinion
Grapevine, November 30, 2025: Mamdani complexities
MBS’s first Washington trip since 2018 brings new investments
COVID: Omicron BA.2 infection after vaccine can protect from BA.4/BA.5 - study
Breakthrough infections of COVID-19 Omicron BA.2 in people who have received the Pfizer/BioNTech vaccine have more antibodies against the dominant BA.4/BA.5 descendants.
Israel's COVID-19 czar fears new wave combined with flu, urges vaccines
Israel's COVID-19 czar Prof. Salman Zarka calls for the voluntary wearing of face masks in risky places and antigen testing as the Jewish High Holy Days approach.
COVID-19 vaccines can significantly reduce long-COVID risk - Israeli study
A new study from Bar-Ilan University shows that eight of the 10 most commonly reported symptoms were reported between 50% and 80% less often among those who received at least two vaccine doses.
Top scientists join forces to study leading theory behind long COVID
A new research group is gathering top scientists to streamline research and quickly pivot to clinical trials of potential treatments for long COVID.
COVID-19: Health Min. offers non-mRNA vaccine, alt. for Pfizer, Moderna
It has obtained supplies of Nuvaxovid from the Novavax company. It is a vaccine that protects against serious complications of the pandemic without being based on mRNA.
Pfizer, Moderna's COVID-19 Omicron vaccine boosters approved by US FDA
Pfizer said it has some doses ready to ship immediately and can deliver up to 15 million doses by September 9.
US to move COVID-19 vaccines, treatments to private markets in 2023
US President Joe Biden's administration expects to run out of federal funding for buying and distributing COVID-19 vaccines by January.
Moderna sues Pfizer and BioNTech over COVID-19 vaccine
Moderna said in a statement that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 that covered its mRNA technology.
COVID-19: Pfizer CEO Albert Bourla tests positive, experiencing mild symptoms
Pfizer CEO Albert Bourla has started the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions.
Pfizer or Sinovac: Which COVID-19 vaccine booster is best? - study
A study on nearly 14 million people in Malaysia who were vaccinated with Pfizer, Sinovac or a combination of the two seems to indicate that Pfizer offers stronger protection.
